CY
Healthcare & Life Sciences
CytoDel
CytoDel is a Healthcare & Life Sciences startup, most recent round Seed, 1 tracked investor.
seed
seed
Stage
1
Investors
About CytoDel
CytoDel is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
CytoDel produces recombinant derivatives of botulinum neurotoxin customized for specific applications using molecular biology techniques.
Explore CytoDel's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.